SCHOTT Pharma AG & Co. KGaA
FSX: 1SXP.F0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Frankfurt Stock Exchange
- Sector
- Healthcare
- Industry
- Medical - Instruments & Supplies
- CEO
- Andreas Reisse
- Employees
- 4,749
- Headquarters
- Mainz, Germany
- IPO year
- 2023
- Market cap
- €2.3B
- Website
- https://www.schott-pharma.com
Loading 1SXP…
Loading profile data…Frequently asked questions about 1SXP
What does SCHOTT Pharma AG & Co. KGaA (1SXP.F) do?
SCHOTT Pharma AG & Co. KGaA develops, produces, and sells drug containment solutions and delivery systems for injectable drugs to the pharmaceutical and biotechnology industries worldwide. The company offers polymer and glass syringes, ampoules, vials, and cartridges. Its syringe products include syriQ, a glass syringe for vaccines; syriQ BioPur...
Where does 1SXP.F trade?
SCHOTT Pharma AG & Co. KGaA (1SXP.F) trades on the Frankfurt Stock Exchange.
What sector is 1SXP.F in?
SCHOTT Pharma AG & Co. KGaA (1SXP.F) operates in the Healthcare sector, specifically in the Medical - Instruments & Supplies industry.
Who is the CEO of SCHOTT Pharma AG & Co. KGaA?
Andreas Reisse is the chief executive officer of SCHOTT Pharma AG & Co. KGaA (1SXP.F).
Where is SCHOTT Pharma AG & Co. KGaA headquartered?
SCHOTT Pharma AG & Co. KGaA is headquartered in Germany.
Does 1SXP.F pay a dividend?
Yes — SCHOTT Pharma AG & Co. KGaA (1SXP.F) paid a trailing twelve-month dividend of EUR 0.18 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did 1SXP.F go public?
SCHOTT Pharma AG & Co. KGaA (1SXP.F) completed its initial public offering in 2023.